Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iguratimod (T614) is an antirheumatic agent, acts as an inhibitor of COX-2, with an IC50 of 20 μM (7.7 μg/mL), but shows no effect on COX-1. Iguratimod also inhibits macrophage migration inhibitory factor (MIF) with an IC50 of 6.81 μM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 43.00 | |
10 mg | In stock | $ 61.00 | |
25 mg | In stock | $ 113.00 | |
50 mg | In stock | $ 207.00 | |
100 mg | In stock | $ 269.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | Iguratimod (T614) is an antirheumatic agent, acts as an inhibitor of COX-2, with an IC50 of 20 μM (7.7 μg/mL), but shows no effect on COX-1. Iguratimod also inhibits macrophage migration inhibitory factor (MIF) with an IC50 of 6.81 μM. |
Targets&IC50 | MIF:6.81μM, COX-2:20μM |
Synonyms | T614 |
Molecular Weight | 374.37 |
Formula | C17H14N2O6S |
CAS No. | 123663-49-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (26.71 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Iguratimod 123663-49-0 Immunology/Inflammation Neuroscience Others COX Inhibitor Cyclooxygenase inhibit T614 T-614 T 614 inhibitor